JPH04501205A - サーマス・アクアティクス(Thermus aquaticus)のDNAポリメラーゼを用いたDNA配列決定法 - Google Patents
サーマス・アクアティクス(Thermus aquaticus)のDNAポリメラーゼを用いたDNA配列決定法Info
- Publication number
- JPH04501205A JPH04501205A JP1510171A JP51017189A JPH04501205A JP H04501205 A JPH04501205 A JP H04501205A JP 1510171 A JP1510171 A JP 1510171A JP 51017189 A JP51017189 A JP 51017189A JP H04501205 A JPH04501205 A JP H04501205A
- Authority
- JP
- Japan
- Prior art keywords
- sequencing
- determination method
- dna
- reaction
- dntp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 109
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 title claims description 10
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 title claims description 10
- 241000589500 Thermus aquaticus Species 0.000 title claims description 3
- 238000001712 DNA sequencing Methods 0.000 title description 15
- 238000006243 chemical reaction Methods 0.000 claims description 113
- 238000012163 sequencing technique Methods 0.000 claims description 95
- 108020004414 DNA Proteins 0.000 claims description 57
- 239000013615 primer Substances 0.000 claims description 47
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 40
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 13
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 13
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 102000053602 DNA Human genes 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 9
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 claims description 8
- HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 claims description 8
- URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 claims description 8
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 claims description 7
- ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 claims description 6
- 239000003155 DNA primer Substances 0.000 claims description 4
- 230000004544 DNA amplification Effects 0.000 claims description 3
- UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims 2
- 108010006785 Taq Polymerase Proteins 0.000 description 40
- 239000000203 mixture Substances 0.000 description 39
- 239000000047 product Substances 0.000 description 36
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 22
- 239000000499 gel Substances 0.000 description 21
- 238000002372 labelling Methods 0.000 description 21
- 239000000872 buffer Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000008901 benefit Effects 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000000137 annealing Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 108010017826 DNA Polymerase I Proteins 0.000 description 4
- 102000004594 DNA Polymerase I Human genes 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 238000000376 autoradiography Methods 0.000 description 4
- 239000013024 dilution buffer Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 239000001226 triphosphate Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000012631 diagnostic technique Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000012177 large-scale sequencing Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 101100314144 Mus musculus Tnip1 gene Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000287462 Phalacrocorax carbo Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 241000251221 Triakidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- -1 d[:TP Chemical compound 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- NLJUOWMZPAVXHU-UHFFFAOYSA-N prop-2-enamide;urea Chemical compound NC(N)=O.NC(=O)C=C NLJUOWMZPAVXHU-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (19)
- 1.ジデオキシヌクレオチドー5′一トリホスフェート鎖伸長停止反応によって 核酸セグメントのヌクレオチド配列を決定する方法であって、該配列が、サーマ ス・アクアティクス(Thermus aquaticus)DNAポリメラー ゼ、4種類のデオキシリポヌクレオチドー5′一トリホスフェート(dNTP) およびジデオキシヌクレオチドー5′一トリホスフェート(ddNTP)の存在 下で鋳型依存的にオリゴヌクレオチドプライマーを伸長させることによって決定 されるヌクレオチド配列決定法。
- 2.上記のプライマーが標識されている、請求項1記載の決定法。
- 3.上記の4種類のdNTPまたはddNTPが標識されている、請求項1記載 の決定法。
- 4.上記の4種類のデオキシリポヌクレオチドー5′一トリホスフェートが、d ATP,dCTP,dGTPおよびTTPである、請求項1記載の決定法。
- 5.上記の4種類のデオキシリポヌクレオチドー5′一トリホスフェートが、d ATP,dCTP,c7dGTPおよびTTPである、請求項1記載の決定法。
- 6.上記の4種類のデオキシリポヌクレオチドー5′一トリホスフェートが、d ATP,dCTP,dITPおよびTTPである、請求項1記載の決定法。
- 7.上記の核酸セグメントが遺伝子増幅法によって生じたものである、請求項1 記載の決定法。
- 8.上記の核酸セグメントが非対称遺伝子増幅法によって生じたものである、請 求項1記載の決定法。
- 9.反応混合物中にKClは存在しない、請求項1記載の決定法。
- 10.上記のDNAポリメラーゼが核酸セグメントの2.5倍モル過剰に存在す る、請求項1記載の決定法。
- 11.上記の伸長反応が、最初に、それぞれの濃度が1RM未満である3種類の 非標識dNTPおよび1種類の標識dNTPの存在下で低温で行われ、続いて、 高濃度の非標識dNTP中で高温で行われる、請求項3記載の決定法。
- 12.c7dGTPがプライマーの伸長中にも存在する、請求項4記載の決定法 。
- 13.各dNTPが5RMないし30RMの濃度で存在する、請求項4記載の決 定法。
- 14.上記の低温伸長反応の間で標識dNTPの濃度が0.5RMであって、各 非標識dNTPの濃度が1.0RMである、請求項11記載の決定法。
- 15.dATP:ddATPの比が1:32である、請求項4記載の決定法。
- 16.dCTP:ddCTPの比が1:16である、請求項4記載の決定法。
- 17.dGTP:ddGTPの比が1:6である、請求項4記載の決定法。
- 18.TTT:ddTTPの比が1:48である、請求項4記載の決定法。
- 19.各dNTPの濃度が10RMである、請求項4記載の決定法。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/249,367 US5075216A (en) | 1988-09-23 | 1988-09-23 | Methods for dna sequencing with thermus aquaticus dna polymerase |
| US249,367 | 1988-09-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04501205A true JPH04501205A (ja) | 1992-03-05 |
| JP2901194B2 JP2901194B2 (ja) | 1999-06-07 |
Family
ID=22943169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1510171A Expired - Lifetime JP2901194B2 (ja) | 1988-09-23 | 1989-09-19 | サーマス・アクアティクス(Thermus aquaticus)のDNAポリメラーゼを用いたDNA配列決定法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5075216A (ja) |
| EP (1) | EP0437459B1 (ja) |
| JP (1) | JP2901194B2 (ja) |
| AT (1) | ATE159762T1 (ja) |
| AU (1) | AU647015B2 (ja) |
| CA (1) | CA1332561C (ja) |
| DE (1) | DE68928413T2 (ja) |
| WO (1) | WO1990003442A1 (ja) |
Families Citing this family (148)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656493A (en) * | 1985-03-28 | 1997-08-12 | The Perkin-Elmer Corporation | System for automated performance of the polymerase chain reaction |
| US5333675C1 (en) * | 1986-02-25 | 2001-05-01 | Perkin Elmer Corp | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| US5173411A (en) * | 1987-01-14 | 1992-12-22 | President And Fellows Of Harvard College | Method for determining the nucleotide base sequence of a DNA molecule |
| US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| KR100236506B1 (ko) * | 1990-11-29 | 2000-01-15 | 퍼킨-엘머시터스인스트루먼츠 | 폴리머라제 연쇄 반응 수행 장치 |
| DE4214112A1 (de) * | 1991-08-02 | 1993-02-04 | Europ Lab Molekularbiolog | Neues verfahren zur sequenzierung von nukleinsaeuren |
| US5674679A (en) * | 1991-09-27 | 1997-10-07 | Amersham Life Science, Inc. | DNA cycle sequencing |
| US5830642A (en) * | 1992-04-03 | 1998-11-03 | Amersham Life Science, Inc. | Electrophoresis of nucleic acid fragments |
| US5314595A (en) * | 1992-04-03 | 1994-05-24 | United States Biochemical Corporation | Electrophoresis of nucleic acid fragments |
| US5436149A (en) * | 1993-02-19 | 1995-07-25 | Barnes; Wayne M. | Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension |
| US6410277B1 (en) * | 1993-02-19 | 2002-06-25 | Takara Shuzo Co., Ltd. | DNA polymersases with enhanced length of primer extension |
| US7465539B1 (en) | 1993-02-19 | 2008-12-16 | Takara Bio, Inc. | DNA polymerases with enhanced length of primer extension |
| US5550040A (en) * | 1993-06-23 | 1996-08-27 | Hoffman-La Roche Inc. | Method, reagents and kits for the detection of Neisseria gonorrhoeae |
| ATE259648T1 (de) * | 1993-10-26 | 2004-03-15 | Univ Jefferson | Verbindungen die kolorektale krebszellen spezifisch binden und verfahren für ihre herstellung |
| US7097839B1 (en) | 1993-10-26 | 2006-08-29 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| US5601990A (en) * | 1994-09-13 | 1997-02-11 | Thomas Jefferson University | Methods of diagnosing colorectal tumors and metastasis thereof |
| US5879656A (en) * | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| US7312052B1 (en) | 1993-12-08 | 2007-12-25 | Stratagene California | Polymerase compositions and uses thereof |
| US5480783A (en) * | 1994-03-31 | 1996-01-02 | The Perkin-Elmer Corporation | Method for reducing background signals in DNA replication/detection assays |
| US6455251B1 (en) | 1994-09-13 | 2002-09-24 | Thomas Jefferson University | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| US5919617A (en) * | 1994-12-21 | 1999-07-06 | Miami University | Methods and reagents for detecting fungal pathogens in a biological sample |
| US5876949A (en) * | 1995-05-31 | 1999-03-02 | The Trustees Of The University Of Pennsylvania | Antibodies specific for fragile X related proteins and method of using the same |
| CA2222744C (en) * | 1995-05-31 | 2008-03-25 | Amersham Life Science, Inc. | Thermostable dna polymerases |
| US6001645A (en) * | 1995-06-07 | 1999-12-14 | Promega Corporation | Thermophilic DNA polymerases from thermotoga neapolitana |
| US6077664A (en) * | 1995-06-07 | 2000-06-20 | Promega Corporation | Thermophilic DNA polymerases from Thermotoga neapolitana |
| US5750345A (en) * | 1995-10-31 | 1998-05-12 | Evanston Hospital Corporation | Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
| US5888736A (en) * | 1995-12-22 | 1999-03-30 | Visible Genetics, Inc. | Method, compositions and kit for detection and identification of microorganisms |
| US5830657A (en) * | 1996-05-01 | 1998-11-03 | Visible Genetics Inc. | Method for single-tube sequencing of nucleic acid polymers |
| US6168918B1 (en) | 1996-01-31 | 2001-01-02 | American Home Products Corp. | Method of detecting foreign DNA integrated in eukaryotic chromosomes |
| US6413718B1 (en) | 1996-05-01 | 2002-07-02 | Visible Genetics Inc. | Method for sequencing of nucleic acid polymers |
| US6602659B1 (en) | 1996-05-03 | 2003-08-05 | Thomas Jefferson University | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| US5910409A (en) * | 1996-05-20 | 1999-06-08 | Miami University | Methods and reagents for detecting fungal pathogens in a biological sample |
| US6455248B1 (en) | 1996-05-20 | 2002-09-24 | Miami University | Reagents and kits for detecting fungal pathogens in a biological sample |
| US5849546A (en) * | 1996-09-13 | 1998-12-15 | Epicentre Technologies Corporation | Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates |
| US6207371B1 (en) | 1996-10-04 | 2001-03-27 | Lexicon Genetics Incorporated | Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| US7332338B2 (en) | 1996-10-04 | 2008-02-19 | Lexicon Pharmaceuticals, Inc. | Vectors for making genomic modifications |
| US6855545B1 (en) | 1996-10-04 | 2005-02-15 | Lexicon Genetics Inc. | Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| US6139833A (en) * | 1997-08-08 | 2000-10-31 | Lexicon Genetics Incorporated | Targeted gene discovery |
| US20040072243A1 (en) * | 1996-10-11 | 2004-04-15 | Lexicon Genetics Incorporated | Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| US6291164B1 (en) | 1996-11-22 | 2001-09-18 | Invitrogen Corporation | Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate |
| DE19653439A1 (de) * | 1996-12-20 | 1998-07-02 | Svante Dr Paeaebo | Verfahren zur direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen und dessen Anwendung |
| US20030215857A1 (en) * | 1996-12-20 | 2003-11-20 | Roche Diagnostics Gmbh | Method for the direct, exponential amplification and sequencing of DNA molecules and its application |
| US6605428B2 (en) | 1996-12-20 | 2003-08-12 | Roche Diagnostics Gmbh | Method for the direct, exponential amplification and sequencing of DNA molecules and its application |
| DE19653494A1 (de) * | 1996-12-20 | 1998-06-25 | Svante Dr Paeaebo | Verfahren zur entkoppelten, direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen unter Zugabe einer zweiten thermostabilen DNA Polymerase und dessen Anwendung |
| US5952200A (en) * | 1997-02-06 | 1999-09-14 | University Of South Carolina | Method of diagnosing cancer in human cells using a reverse transcriptase-polymerase chain reaction for identifying the presence of stromelysin-3 |
| US6187536B1 (en) | 1997-02-18 | 2001-02-13 | Thomas Jefferson University | Methods of identifying and detecting pancreatic cancer |
| JP4245084B2 (ja) | 1997-03-21 | 2009-03-25 | ストラタジーン | ポリメラーゼ増強因子(pef)抽出物、pefタンパク質複合体、単離されたpefタンパク質、並びに精製及び単離方法 |
| US6391622B1 (en) | 1997-04-04 | 2002-05-21 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
| AU746892B2 (en) * | 1997-04-04 | 2002-05-02 | Caliper Life Sciences, Inc. | Closed-loop biochemical analyzers |
| US6235471B1 (en) | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
| US6120995A (en) * | 1997-08-07 | 2000-09-19 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| US7135333B1 (en) | 1997-08-07 | 2006-11-14 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| US6103468A (en) * | 1997-10-07 | 2000-08-15 | Labatt Brewing Company Limited | Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer |
| DE69942444D1 (de) * | 1998-02-04 | 2010-07-15 | Life Technologies Corp | Bestimmung des genotyps eines amplifikationsproduktes an mehreren allelen stellen |
| US6808921B1 (en) * | 1998-03-27 | 2004-10-26 | Lexicon Genetics Incorporated | Vectors for gene mutagenesis and gene discovery |
| US6436707B1 (en) * | 1998-03-27 | 2002-08-20 | Lexicon Genetics Incorporated | Vectors for gene mutagenesis and gene discovery |
| WO1999058724A1 (en) * | 1998-05-08 | 1999-11-18 | Life Technologies, Inc. | A method for synthesizing a nucleic acid molecule using a ribonuclease |
| EP2277998B1 (en) | 1998-08-06 | 2016-04-20 | Duke University | Urate oxidase |
| US6333403B1 (en) * | 1998-11-06 | 2001-12-25 | Myriad Genetics, Inc. | Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| EP1074633A1 (en) * | 1999-07-05 | 2001-02-07 | LION Bioscience AG | Nucleotides for cycle sequencing of gc-rich templates |
| GB9922971D0 (en) * | 1999-09-29 | 1999-12-01 | Secr Defence | Reaction system |
| US6893819B1 (en) * | 2000-11-21 | 2005-05-17 | Stratagene California | Methods for detection of a nucleic acid by sequential amplification |
| US7838225B2 (en) | 1999-10-29 | 2010-11-23 | Hologic, Inc. | Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase |
| US7824859B2 (en) * | 1999-10-29 | 2010-11-02 | Cytyc Corporation | Methods for detection of a target nucleic acid by forming a cleavage structure using an RNA polymerase |
| US7118860B2 (en) | 1999-10-29 | 2006-10-10 | Stratagene California | Methods for detection of a target nucleic acid by capture |
| WO2001061015A2 (en) | 2000-02-17 | 2001-08-23 | Qiagen Gmbh | Thermostable chimeric nucleic acid polymerases and uses thereof |
| US6632645B1 (en) | 2000-03-02 | 2003-10-14 | Promega Corporation | Thermophilic DNA polymerases from Thermoactinomyces vulgaris |
| US6436677B1 (en) * | 2000-03-02 | 2002-08-20 | Promega Corporation | Method of reverse transcription |
| ATE452989T1 (de) | 2000-03-27 | 2010-01-15 | Univ Jefferson | Zusammensetzungen und methoden zur identifizierung von krebszellen |
| EP1182267B1 (en) * | 2000-03-30 | 2012-01-18 | Toyota Jidosha Kabushiki Kaisha | Method of determining base sequence of single nucleic acid molecule |
| US20080242627A1 (en) * | 2000-08-02 | 2008-10-02 | University Of Southern California | Novel rna interference methods using dna-rna duplex constructs |
| US7662791B2 (en) * | 2000-08-02 | 2010-02-16 | University Of Southern California | Gene silencing using mRNA-cDNA hybrids |
| US7829276B2 (en) * | 2000-09-18 | 2010-11-09 | Thomas Jefferson University | Methods of using CRCA-1 as a stomach and esophageal cancer marker |
| DE10049211A1 (de) * | 2000-10-05 | 2002-04-18 | Qiagen Gmbh | Thermostabile Polymerase aus Thermococcus pacificus |
| GB0110476D0 (en) * | 2001-04-30 | 2001-06-20 | Secr Defence | Reagent delivery system |
| US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| WO2003040376A1 (en) * | 2001-11-02 | 2003-05-15 | Olga Makarova | Method for site-directed mutagenesis of nucleic acid molecules using a single primer |
| US7222059B2 (en) * | 2001-11-15 | 2007-05-22 | Siemens Medical Solutions Diagnostics | Electrophoretic trace simulator |
| US20030180741A1 (en) | 2001-12-21 | 2003-09-25 | Holly Hogrefe | High fidelity DNA polymerase compositions and uses therefor |
| US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
| CA2477761A1 (en) * | 2002-03-01 | 2003-09-12 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US20050202429A1 (en) * | 2002-03-20 | 2005-09-15 | Innovativebio.Biz | Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartment for parallels reactions |
| US20030228611A1 (en) * | 2002-05-01 | 2003-12-11 | President And Fellows Of Harvard College | Nucleic acid memory device |
| US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US20030210489A1 (en) * | 2002-05-13 | 2003-11-13 | Yec Co., Ltd. | Data eraser and data erasing program |
| DE602004025801D1 (de) | 2003-03-25 | 2010-04-15 | Stratagene California | Dna-polymerasefusionen und deren verwendungen |
| US7820030B2 (en) | 2003-04-16 | 2010-10-26 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
| JP4440921B2 (ja) | 2003-04-21 | 2010-03-24 | エフ.ホフマン−ラ ロシュ アーゲー | 肥満及び骨粗鬆症を有すfrzb遺伝子における多型の関連性 |
| US7892745B2 (en) | 2003-04-24 | 2011-02-22 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| WO2005003388A2 (en) * | 2003-06-30 | 2005-01-13 | Astrazeneca Ab | Fluorescence assays for nucleic acid polymerase activity |
| US7179602B2 (en) * | 2003-09-04 | 2007-02-20 | Los Alamos National Security, Llc | Methods for sequencing GC-rich and CCT repeat DNA templates |
| MXPA06003572A (es) * | 2003-09-30 | 2006-08-31 | Lexicon Genetics Inc | Metodos y composiciones para definir la funcion genetica. |
| WO2005054435A2 (en) * | 2003-11-26 | 2005-06-16 | Eppendorf Ag | Methods and compositions for in vitro amplification of extrachromosomal nucleic acid |
| US8293471B2 (en) * | 2004-01-28 | 2012-10-23 | Marshall University Research Corporation | Apparatus and method for a continuous rapid thermal cycle system |
| WO2006029184A2 (en) | 2004-09-08 | 2006-03-16 | Expression Diagnostics, Inc. | Genes useful for diagnosing and monitoring inflammation related disorders |
| CA2586246A1 (en) * | 2004-11-03 | 2006-05-11 | Third Wave Technologies, Inc. | Single step nucleic acid detection assay employing reverse transcription, polymerase chain reaction and endonuclease cleavage |
| US7051536B1 (en) * | 2004-11-12 | 2006-05-30 | Bio-Rad Laboratories, Inc. | Thermal cycler with protection from atmospheric moisture |
| JP2006230342A (ja) * | 2005-02-28 | 2006-09-07 | Tokyo Univ Of Agriculture & Technology | 一本鎖核酸の分離方法および装置並びにマイクロアレイおよびdnaチップ。 |
| GB0514935D0 (en) | 2005-07-20 | 2005-08-24 | Solexa Ltd | Methods for sequencing a polynucleotide template |
| JP5106416B2 (ja) | 2006-01-06 | 2012-12-26 | アジレント・テクノロジーズ・インク | 濃縮(packed)DNAポリメラーゼを含む核酸複製のための反応緩衝液組成物 |
| RU2406093C2 (ru) * | 2006-02-02 | 2010-12-10 | Корбетт Лайф Сайнс Пти Лтд | Устройство и способ ввода жидкой пробы в поток флюидного носителя и их применение для амплификации нуклеиновой кислоты |
| US10741034B2 (en) | 2006-05-19 | 2020-08-11 | Apdn (B.V.I.) Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
| US7993832B2 (en) | 2006-08-14 | 2011-08-09 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders |
| EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| US9938641B2 (en) * | 2006-12-18 | 2018-04-10 | Fluidigm Corporation | Selection of aptamers based on geometry |
| AU2008222590B2 (en) * | 2007-03-02 | 2013-01-17 | Qiagen Instruments Ag | Apparatus and method for nucleic acid amplification |
| EP2190566B1 (en) * | 2007-08-28 | 2012-10-03 | Corbett Research Pty Ltd | Thermal cycling device with selectively openable sample port |
| SG10201402188TA (en) | 2007-11-30 | 2014-06-27 | Corbett Res Pty Ltd | Thermal cycling device |
| CN102027128A (zh) * | 2008-02-11 | 2011-04-20 | 哈达斯特医学服务与开发有限公司 | 作为癌症标志物的结肠癌相关的转录物1(ccat-1) |
| CN102301000B (zh) * | 2008-03-15 | 2015-04-29 | 豪洛捷公司 | 核酸分子扩增反应的分析组分及方法 |
| EP3629022A1 (en) | 2008-07-25 | 2020-04-01 | Richard W. Wagner | Protein screening methods |
| CA2638458A1 (en) * | 2008-07-31 | 2010-01-31 | Spartan Bioscience Inc. | Thermal recycling by positioning relative to fixed-temperature source |
| WO2010033604A2 (en) * | 2008-09-18 | 2010-03-25 | X-Bar Diagnostic System, Inc. | Fully automated portable dna detection system |
| ES2571446T3 (es) | 2008-11-03 | 2016-05-25 | Kapa Biosystems Inc | ADN polimerasas quiméricas |
| US10457968B2 (en) | 2008-11-03 | 2019-10-29 | Kapa Biosystems, Inc. | Modified type A DNA polymerases |
| US20110070590A1 (en) | 2009-09-22 | 2011-03-24 | Jan Rohozinski | Primers and Methods for Determining RhD Zygosity |
| EP2531613A2 (en) | 2010-02-02 | 2012-12-12 | Abbott Biotechnology Ltd. | Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor |
| WO2011127136A1 (en) * | 2010-04-06 | 2011-10-13 | University Of Chicago | Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc) |
| EP2560759B1 (en) | 2010-04-20 | 2020-02-12 | QIAGEN GmbH | Temperature control method and apparatus |
| US8618253B2 (en) | 2010-05-25 | 2013-12-31 | Samsung Techwin Co., Ltd. | Modified RNAse H and detection of nucleic acid amplification |
| WO2012097318A2 (en) | 2011-01-14 | 2012-07-19 | Kap Abiosystems | Modified dna polymerases for improved amplification |
| ES2731653T3 (es) | 2011-03-18 | 2019-11-18 | Eisai R&D Man Co Ltd | Métodos y usos para predecir la respuesta a la eribulina |
| CA2852268C (en) | 2011-10-20 | 2020-08-25 | Novartis Ag | Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| WO2013057308A2 (en) | 2011-10-20 | 2013-04-25 | Qiagen Instruments Ag | Method for verifying a temperature measurement in a micro-environment and system for verifying a temperature measurement in a micro-environment |
| WO2013139970A1 (en) | 2012-03-23 | 2013-09-26 | Qiagen Instruments Ag | Thermal cycler and method for heating and cooling |
| US20140024541A1 (en) * | 2012-07-17 | 2014-01-23 | Counsyl, Inc. | Methods and compositions for high-throughput sequencing |
| EP2687294A1 (en) | 2012-07-18 | 2014-01-22 | Qiagen Instruments AG | Rotor for a thermal cycler and thermal cycler |
| CA2894384C (en) | 2012-12-11 | 2018-03-06 | Novartis Ag | Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| US9963740B2 (en) | 2013-03-07 | 2018-05-08 | APDN (B.V.I.), Inc. | Method and device for marking articles |
| WO2015054188A1 (en) | 2013-10-07 | 2015-04-16 | Apdn (B.V.I), Inc. | Multimode image and spectral reader |
| MX371445B (es) | 2013-10-15 | 2020-01-30 | Bio Molecular Systems Pty Ltd | Reciclador térmico perfeccionado. |
| WO2015120130A1 (en) | 2014-02-07 | 2015-08-13 | Novartis Ag | Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy |
| US10745825B2 (en) | 2014-03-18 | 2020-08-18 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
| CN106103121B (zh) | 2014-03-18 | 2019-12-06 | 亚普蒂恩(B.V.I.)公司 | 用于安全应用的加密光学标记物 |
| WO2017049118A2 (en) | 2015-09-18 | 2017-03-23 | Siemens Healthcare Diagnostics Inc. | Reagents and methods for analysis of hiv |
| CN108350407B (zh) | 2015-12-11 | 2022-07-08 | 杰诺玛迪克斯公司 | 用于核酸扩增的管密封系统和方法 |
| CN109070130B (zh) | 2016-04-11 | 2022-03-22 | 亚普蒂恩(B V I)公司 | 用于标记纤维素产品的方法 |
| EP3478702A4 (en) | 2016-06-27 | 2020-03-18 | Dana-Farber Cancer Institute, Inc. | METHOD FOR MEASURING RNA TRANSLATION RATES |
| MA45455A (fr) | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Procédé d'identification d'épitopes peptidiques, molécules qui se lient à de tels épitopes et utilisations associées |
| US20190324030A1 (en) | 2016-06-27 | 2019-10-24 | Juno Therapeutics, Inc. | Mhc-e restricted epitopes, binding molecules and related methods and uses |
| US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
| WO2018156352A1 (en) | 2017-02-21 | 2018-08-30 | Apdn (B.V.I) Inc. | Nucleic acid coated submicron particles for authentication |
| US11851679B2 (en) | 2017-11-01 | 2023-12-26 | Juno Therapeutics, Inc. | Method of assessing activity of recombinant antigen receptors |
| CA3223867A1 (en) | 2021-06-30 | 2023-01-05 | Gerassimos Makrigiorgos | Compositions and methods for enrichment of nucleic acids using light-mediated cross-linking |
| WO2025049432A1 (en) | 2023-08-28 | 2025-03-06 | Intellia Therapeutics, Inc. | Methods for editing hla-a in cells pre-screened for the absence of one or both alleles of hla-h*01 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| CA1339653C (en) * | 1986-02-25 | 1998-02-03 | Larry J. Johnson | Appartus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| CA1338457C (en) * | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
| US4795699A (en) * | 1987-01-14 | 1989-01-03 | President And Fellows Of Harvard College | T7 DNA polymerase |
| US4921794A (en) * | 1987-01-14 | 1990-05-01 | President And Fellows Of Harvard College | T7 DNA polymerase |
| US4962020A (en) * | 1988-07-12 | 1990-10-09 | President And Fellows Of Harvard College | DNA sequencing |
| DE69002826T2 (de) * | 1989-02-06 | 1994-03-31 | Eastman Kodak Co | Reaktionskonzentrat zur dna-sequenzierung mit thermostabiler dna-polymerase. |
| US5001050A (en) * | 1989-03-24 | 1991-03-19 | Consejo Superior Investigaciones Cientificas | PHφ29 DNA polymerase |
-
1988
- 1988-09-23 US US07/249,367 patent/US5075216A/en not_active Expired - Lifetime
-
1989
- 1989-09-19 AT AT89910787T patent/ATE159762T1/de not_active IP Right Cessation
- 1989-09-19 WO PCT/US1989/004093 patent/WO1990003442A1/en not_active Ceased
- 1989-09-19 JP JP1510171A patent/JP2901194B2/ja not_active Expired - Lifetime
- 1989-09-19 DE DE68928413T patent/DE68928413T2/de not_active Expired - Lifetime
- 1989-09-19 AU AU43003/89A patent/AU647015B2/en not_active Expired
- 1989-09-19 EP EP89910787A patent/EP0437459B1/en not_active Expired - Lifetime
- 1989-09-22 CA CA000612500A patent/CA1332561C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0437459A1 (en) | 1991-07-24 |
| AU647015B2 (en) | 1994-03-17 |
| DE68928413T2 (de) | 1998-06-04 |
| US5075216A (en) | 1991-12-24 |
| ATE159762T1 (de) | 1997-11-15 |
| AU4300389A (en) | 1990-04-18 |
| EP0437459B1 (en) | 1997-10-29 |
| JP2901194B2 (ja) | 1999-06-07 |
| CA1332561C (en) | 1994-10-18 |
| DE68928413D1 (de) | 1997-12-04 |
| WO1990003442A1 (en) | 1990-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH04501205A (ja) | サーマス・アクアティクス(Thermus aquaticus)のDNAポリメラーゼを用いたDNA配列決定法 | |
| US11466315B2 (en) | Fast PCR for STR genotyping | |
| US5683869A (en) | Method of nucleic acid sequencing | |
| EP1539979B1 (en) | Helicase dependent amplification of nucleic acids | |
| JP3140937B2 (ja) | 好熱酵素を用いる鎖置換増幅法 | |
| US6300070B1 (en) | Solid phase methods for amplifying multiple nucleic acids | |
| US7662594B2 (en) | Helicase-dependent amplification of RNA | |
| JP3509025B2 (ja) | 不連続プライマー伸長による核酸の反復配列長の決定 | |
| JPH11503919A (ja) | 核酸の同時配列決定 | |
| NZ227688A (en) | Amplification and detection of nucleic acid sequences by synthesis of specific rna transcripts | |
| JP2004512823A (ja) | 核酸配列の多重プライミング増幅プロセス | |
| EA004327B1 (ru) | Способ амплификации последовательности нуклеиновой кислоты | |
| JP2002503482A (ja) | Dna増幅法および配列決定方法 | |
| WO2012022755A1 (en) | Helicase dependent isothermal amplification using nicking enzymes | |
| JPH08322600A (ja) | 3’−固有の校正活性を有するdnaポリメラーゼの使用 | |
| CN102066574A (zh) | 利用非天然核苷酸扩增dna的过程 | |
| JP4249186B2 (ja) | 核酸の増幅方法 | |
| JPH06245799A (ja) | 非放射性dna配列 | |
| CN105658811A (zh) | 利用核苷酸类似物和解旋酶恒温扩增dna分子的方法 | |
| CN100519758C (zh) | 核酸的解旋酶依赖性扩增 | |
| JPS63500006A (ja) | エキソヌクレア−ゼ阻害による核酸の塩基配列決定法 | |
| CN104350159A (zh) | 制备在利用核酸聚合酶来检测核酸时使用的高精度核酸的方法 | |
| AU2015270298B2 (en) | Methods of reducing density-dependent GC bias in amplification | |
| EP1624059A2 (en) | Method of producing nucleic acid molecules with reduced secondary structure | |
| EP2450453A2 (en) | Method for the replication, amplification or sequencing of a dna template |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080319 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 11 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 11 |